Treatment strategy for BVO-ME based on long-term outcomes correlating retinal structure by OCT image and visual acuity

BACKGROUND: Intravitreal anti-vascular endothelial growth factor (VEGF) is a mainstream treatment for reducing ME secondary to BRVO (BVO-ME). Regrettably, most reports of intravitreal anti-VEGF for BVO-ME have disclosed only short-term outcomes. Here, we characterized long-term indicators for the vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Yuki, Fujiwara, Ryo, Mori, Hidetsugu, Kimura, Motoki, Yamada, Haruhiko, Takahashi, Kanji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510278/
https://www.ncbi.nlm.nih.gov/pubmed/37726720
http://dx.doi.org/10.1186/s12886-023-03138-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510278/
https://www.ncbi.nlm.nih.gov/pubmed/37726720
http://dx.doi.org/10.1186/s12886-023-03138-2

Ejemplares similares